Vor Biopharma Inc (VOR)

16.06 +4.63%

Vor Biopharma Inc (VOR) is currently trading at $16.06. This represents a gain of 4.63% from the previous session. With a market capitalization of $0.67B, VOR is a key component of the Health Care sector. Investors looking to trade VOR should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade VOR commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Vor Biopharma Inc (VOR) shows a bullish trend. Analysts are watching the 17.09 level closely.

Fundamentals
Mkt Cap0.67B
P/E Ratio0.0000
Volume1,062,688
Others Watching (By Market Cap)
MD
Pediatrix Medic $19.90
-0.80% ARDX
Ardelyx Inc $6.56
+0.00% HRMY
Harmony Bioscie $28.19
+0.00% NRIX
Nurix Therapeut $15.79
-1.44% QDEL
Quidelortho Cor $23.33
+6.38%
60-Day Technical Chart
Advanced Charting

Need more indicators for VOR? Use the world's #1 platform.

Open VOR on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $16
Metric VOR
+4.63% 		HIMS
+2.33% 		RKT
-2.15% 		RGTI
+6.98%
Price $16.06 $15.82 $17.33 $17.63
Mkt Cap $0.67B $3.63B $48.80B $5.82B
- View → View → View →
Latest Headlines
Vor Biopharma (Nasdaq: VOR) prices 10,000,000-share stock offering for $100M Stock Titan • Nov 10, 2025 Is There An Opportunity With Vor Biopharma Inc.'s (NASDAQ:VOR) 49% Undervaluation? Yahoo Finance • Dec 2, 2025 JPMorgan initiates Vor Biopharma stock with Overweight rating on telitacicept potential Investing.com • Dec 9, 2025 VOR: TD Cowen Initiates Coverage with a 'Buy' Rating | VOR Stock News GuruFocus • Dec 17, 2025 Vor Biopharma: J.P. Morgan Makes Bull Case After Corporate Actions Slam Stock Price (VOR) Seeking Alpha • Dec 10, 2025
● Gemini Agentic AI Analyst Insight for VOR
Market Education
View All Articles →
External Research